Preconditioning determines engraftment and therapeutic efficacy of anti-CD19 CAR-T cells in murine lupus
J Immunol. 2026 May 14;215(5):vkag112. doi: 10.1093/jimmun/vkag112. ABSTRACT Anti-CD19 chimeric antigen receptor (CAR) T cells have emerged as a promising therapeutic strategy for autoimmune diseases, including systemic lupus erythematosus. An unresolved question is how immunosuppressive preconditioning regimens influence CAR-T cell engraftment and therapeutic efficacy. In murine models, whole-body irradiation is required for optimal CAR-T cell … Read more